Evogene (EVGN) Stock Price, News & Analysis

Company Overview

EverGen Infrastructure Corp is focused on combating climate change and helping communities contribute to a carbon-free future to develop a Renewable Natural Gas Infrastructure Platform, starting on the West Coast of Canada in British Columbia. The company is established to acquire, develop, build, own and operate a portfolio of renewable natural gas, waste to energy, and related infrastructure projects.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$1.50
• Consensus Rating: Moderate Buy

EVGN Stock Analysis - Frequently Asked Questions

How do I buy shares of Evogene?

Shares of EVGN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Evogene own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Evogene investors own include Hyliion (HYLN), Purple Biotech (PPBT), Viper Networks (VPER), Butterfly Network (BFLY), Alibaba Group (BABA) and AquaBounty Technologies (AQB).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Manufacturing
• Industry: Pesticide & Other Agricultural Chemical Manufacturing
• Sub-Industry: Chemicals
• Current Symbol: TSE:EVGN
• CIK: N/A
• Web: www.evogene.com
• Phone: 97289311900
• Fax: N/A
• Employees: 140
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Evogene: C$1.50
• High Price Target: C$2.00
• Low Price Target: C$1.00
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A